In peripheral artery disease, which approach is considered a core part of treatment?

In peripheral artery disease, which approach is considered a core part of treatment?

• A. Only surgery
• B. Aggressive risk factor modification and exercise
• C. No therapy
• D. Only anti-platelet therapy

Answer: (B)

In PAD, the most important, foundational treatment is aggressive risk-factor modification together with a structured exercise program. This approach targets the systemic atherosclerosis and directly improves functional capacity, reducing symptoms like claudication and lowering future cardiovascular risk. Supervised exercise, especially walking programs, enhances walking distance and muscle efficiency, and it helps improve endothelial function and collateral development. Risk-factor modification includes quitting smoking, controlling cholesterol with statins, maintaining blood pressure, and achieving good blood glucose control in diabetics. Anti-platelet therapy is helpful to reduce cardiovascular events, but it doesn’t by itself improve walking distance or reverse the underlying disease, and surgery or revascularization is reserved for cases with critical limb ischemia or when symptoms persist despite optimal medical management. So the combination of aggressive lifestyle and risk management with exercise sits at the core of treatment.

In PAD, the most important, foundational treatment is aggressive risk-factor modification together with a structured exercise program. This approach targets the systemic atherosclerosis and directly improves functional capacity, reducing symptoms like claudication and lowering future cardiovascular risk. Supervised exercise, especially walking programs, enhances walking distance and muscle efficiency, and it helps improve endothelial function and collateral development. Risk-factor modification includes quitting smoking, controlling cholesterol with statins, maintaining blood pressure, and achieving good blood glucose control in diabetics. Anti-platelet therapy is helpful to reduce cardiovascular events, but it doesn’t by itself improve walking distance or reverse the underlying disease, and surgery or revascularization is reserved for cases with critical limb ischemia or when symptoms persist despite optimal medical management. So the combination of aggressive lifestyle and risk management with exercise sits at the core of treatment.